The potential of stem cells as an in vitro source of red blood cells for transfusion

Cell Stem Cell

Volumn 10, Issue 2, 2012, Pages 115-119

  Migliaccio, Anna Rita ^a,e   Whitsett, Carolyn ^b   Papayannopoulou, Thalia ^c   Sadelain, Michel ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ANTIGEN EXPRESSION; BLOOD TRANSFUSION; CELL MEMBRANE POTENTIAL; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; ERYTHROCYTE; HEMOLYTIC ANEMIA; HEMOPHILIA; HOMOLOGOUS RECOMBINATION; HUMAN; IN VITRO STUDY; MYELODYSPLASTIC SYNDROME; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; STEM CELLS;

EID: 84856729259     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.01.001     Document Type: Review

References (22)

1. A.H. Chang, M.T. Stephan, and M. Sadelain Stem cell-derived erythroid cells mediate long-term systemic protein delivery Nat. Biotechnol. 24 2006 1017 1021 (Pubitemid 44215396)
2. K.H. Chang, A.M. Nelson, H. Cao, L. Wang, B. Nakamoto, C.B. Ware, and T. Papayannopoulou Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin Blood 108 2006 1515 1523 (Pubitemid 44316116)
3. C.J. Chang, K. Mitra, M. Koya, M. Velho, R. Desprat, J. Lenz, and E.E. Bouhassira Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells PLoS ONE 6 2011 e25761
4. P. Chaurasia, D. Berenzon, and R. Hoffman Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells Blood 117 2011 4632 4641
5. M.C. Giarratana, H. Rouard, A. Dumont, L. Kiger, I. Safeukui, P.Y. Le Pennec, S. Franois, G. Trugnan, T. Peyrard, and T. Marie Proof of principle for transfusion of in vitro-generated red blood cells Blood 118 2011 5071 5079
6. T. Hiroyama, K. Miharada, K. Sudo, I. Danjo, N. Aoki, and Y. Nakamura Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells PLoS One 3 2008 e1544
7. T. Hiroyama, K. Miharada, R. Kurita, and Y. Nakamura Plasticity of cells and ex vivo production of red blood cells Stem Cells Int 2011 2011 195780
8. G.J. Housler Compartmental Hollow Fiber Capillary Membrane Based Bioreactor Technology for in vitro Studies on Red Blood Cell Lineage Direction of Hematopoietic Stem Cells Tissue Eng. Part C Methods 2011 10.1089/ten.tec. 2011.0305 in press. Published online December 28, 2011
9. Z. Hu, N. Van Rooijen, and Y.-G. Yang Macrophages prevent human red blood cell reconstitution in immunodeficient mice Blood 118 2011 5938 5946
10. G. Keerthivasan, S. Small, H. Liu, A. Wickrema, and J.D. Crispino Vesicle trafficking plays a novel role in erythroblast enucleation Blood 116 2010 3331 3340
11. H.O. Kim, and E.J. Baek Red Blood Cell Engineering in Stroma and Serum/Plasma-Free Conditions and Long Term Storage Tissue Eng. Part A 18 2011 117 126
12. S.J. Lu, Q. Feng, J.S. Park, L. Vida, B.S. Lee, M. Strausbauch, P.J. Wettstein, G.R. Honig, and R. Lanza Biologic properties and enucleation of red blood cells from human embryonic stem cells Blood 112 2008 4475 4484
13. A.R. Migliaccio, C. Whitsett, and G. Migliaccio Erythroid cells in vitro: from developmental biology to blood transfusion products Curr. Opin. Hematol. 16 2009 259 268
14. K. Miharada, T. Hiroyama, K. Sudo, T. Nagasawa, and Y. Nakamura Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells Nat. Biotechnol. 24 2006 1255 1256 (Pubitemid 44564771)
15. C. Natanson, S.J. Kern, P. Lurie, S.M. Banks, and S.M. Wolfe Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis JAMA 299 2008 2304 2312 (Pubitemid 351724397)
16. E.P. Papapetrou, G. Lee, N. Malani, M. Setty, I. Riviere, L.M. Tirunagari, K. Kadota, S.L. Roth, P. Giardina, and A. Viale Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells Nat. Biotechnol. 29 2011 73 78
17. T. Peyrard, L. Bardiaux, C. Krause, L. Kobari, H. Lapillonne, G. Andreu, and L. Douay Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges Transfus. Med. Rev. 25 2011 206 216
18. N.E. Timmins, S. Athanasas, M. Günther, P. Buntine, and L.K. Nielsen Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells Tissue Eng. Part C Methods 17 2011 1131 1137
19. Y. Wang, Y. Ono, Y. Ikeda, S. Okamoto, M. Murata, M. Poncz, and Y. Matsubara Induction of Megakaryocytes From Fibroblasts by p45NF-E2/Maf Blood 11 2011 908a
20. S. Yamanaka, and H.M. Blau Nuclear reprogramming to a pluripotent state by three approaches Nature 465 2010 704 712
21. J.C. Zimring, L. Welniak, J.W. Semple, P.M. Ness, S.J. Slichter, S.L. Spitalnik NHLBI Alloimmunization Working Group Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group Transfusion 51 2011 435 441
22. J. Zou, P. Mali, X. Huang, S.N. Dowey, and L. Cheng Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease Blood 118 2011 4599 4608